GLP-1 Weight Loss Program
GLP-1 Weight Loss at Rejuvia Semaglutide, Tirzepatide & Retatrutide — Dallas, TX
The conversation around weight loss has changed. GLP-1 medications are not a shortcut, a trend, or a quick fix. They are a real, evidence-based tool for clients who have struggled with weight, appetite regulation, metabolic health, and the deeper biology that diet and exercise alone cannot always override.
At Rejuvia, GLP-1 therapy is a medical program, not a prescription handoff. Every client begins with a clinical intake, lab review where indicated, and a treatment plan built around their goals, their health history, and their long-term metabolic picture.
What GLP-1 Medications Do
GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes that have transformed the treatment of obesity and metabolic disease. They work by mimicking a hormone your body already produces — GLP-1 — which regulates appetite, blood sugar, gastric emptying, and the brain's reward response to food.
For most clients, the result is a quieter relationship with food. Less constant thinking about the next meal. Smaller portions, satisfied sooner. A real, sustained reduction in cravings. And, paired with thoughtful nutrition and movement, meaningful and durable weight loss.
The Medications We Offer
Semaglutide
The original GLP-1 medication for weight loss. Well-studied, well-tolerated for most clients, and an excellent starting point for those new to GLP-1 therapy.
Tirzepatide
A dual-action GIP/GLP-1 medication. In clinical studies, tirzepatide has consistently produced greater weight loss than semaglutide and is often our recommendation for clients with higher weight loss goals or those who plateau on semaglutide.
Retatrutide
A next-generation triple-agonist medication targeting GLP-1, GIP, and glucagon receptors. We offer retatrutide for clients who are candidates for the most advanced GLP-1 therapy currently available.
How Our Program Works
Every GLP-1 program at Rejuvia begins with a medical consultation. We'll review your health history, current medications, prior weight loss history, and clinical labs where indicated. We'll confirm you're a candidate, walk you through what to expect, and select the medication and dose that fits your goals.
From there, you'll choose how you want to receive your treatment:
- In-office weekly injections. You come in once a week for your dose. We handle storage, dosing, and titration. This is the structure most clients start with — it's the most supervised, and it makes dose adjustments and side effect management seamless.
- Take-home vials. For clients who prefer the flexibility of self-administering at home. Requires a brief training visit and ongoing clinical follow-up.
- Single-injection visits. For clients who want to start without a monthly commitment, or who travel and need flexibility.
Dose titration is gradual and individualized. We start low, increase slowly, and adjust based on your response, your tolerance, and your goals. There is no universal "right dose" — there's the right dose for you, and we'll find it together.
In-Office Injection Pricing
Monthly programs start at $150/month (member pricing from $128/month) for semaglutide, and $270/month (member pricing from $230/month) for tirzepatide. Pricing scales with dose. We'll quote your exact monthly investment based on your clinical plan at your consultation.
Single injections start at $50 (member pricing from $42) for semaglutide, and $90 (member pricing from $76) for tirzepatide. Per-injection pricing is the same medication, on your schedule — ideal for clients who want to try GLP-1 therapy without a monthly commitment.
The Wellness Pass — Our Best Value for GLP-1 Clients
Most clients on GLP-1 therapy stay on it for several months, and many find the Wellness Pass is the most cost-effective way to structure their program. The Wellness Pass is $349/month and includes:
- Weekly GLP-1 injection (semaglutide up to 1.45 mg/wk or tirzepatide up to 6 mg/wk)
- Monthly custom facial
- Weekly vitamin shot
- One VI Peel or microneedling treatment per year
- 15% off all other services and retail
For most clients, the included GLP-1 dose covers the full therapeutic range. For clients who escalate above the included cap, the Wellness Pass continues to deliver substantial value — you pay only the difference between your dose tier and the included cap (at member pricing), in addition to the monthly membership. You're never paying full price for higher doses. We'll walk you through whether the Wellness Pass is the right fit for your program at your consultation, and most clients who plan to stay on GLP-1 for three months or more come out ahead by joining.
Take-Home Vials
For clients who prefer to self-administer at home, take-home GLP-1 vials are available after an initial in-office program or with clinical clearance at consultation.
Take-home pricing starts at:
- Semaglutide $175/month (member pricing from $149/month)
- Tirzepatide $315/month (member pricing from $268/month)
- Retatrutide $465/month (member pricing from $395/month)
Take-home programs include the vial, the appropriate syringes and supplies, written dosing instructions, and ongoing clinical follow-up. A brief in-office training visit is required before your first take-home cycle to ensure you're comfortable with self-injection technique, storage, and dose measurement.
Please note: Silver and gold wallet credit does not apply to take-home vials, but the 15% member discount does.
What to Expect
Most clients begin to notice reduced appetite and improved satiety within the first one to two weeks. Visible weight changes typically begin in weeks three to four. Clinically significant weight loss (5–15% of body weight) is most often seen between months three and six, with continued progress into months six through twelve.
Side effects are usually mild and most often resolve as your body adjusts to the medication. The most common are nausea, fatigue, constipation, and reduced appetite (which is the medication working — but can occasionally be too pronounced and require a dose adjustment). We screen for and address side effects at every visit, and dose adjustments are part of the standard program.
Who's a Candidate
GLP-1 therapy at Rejuvia is available for adults with a BMI of 27 or greater (or 25 or greater with a weight-related comorbidity), and for clients pursuing metabolic optimization under appropriate clinical criteria.
GLP-1 medications are not appropriate for clients who are pregnant or breastfeeding, who have a personal or family history of medullary thyroid carcinoma or MEN2, who have a history of pancreatitis, or who have certain other medical conditions we'll screen for at your consultation.
Book a Free Consultation
GLP-1 therapy is a meaningful clinical decision and a long-term investment in your health. The best way to know if it's right for you, which medication fits your goals, and how the program will be structured around your life is to come in. You're never obligated or pressured to start the same day.
Additional Info
- Consults are free!
- Your initiation visit is $100 and includes lab review, medical clearance, program design, and prescribing.
- On-site lab draws are available for added convenience.
- All medication is compounded at a licensed pharmacy and customized for you (based on plan tier)
- Physician-directed care with support from on-site medical staff
- Priority support & ongoing dose guidance
- Weekly check-ins, either virtually or on-site with injection administration
- Monthly progress visit and dose adjustment (if needed)
🔬 Semaglutide vs. Tirzepatide vs. Retatrutide
All medications are powerful GLP-1 receptor agonists used in medically supervised weight loss programs—but they differ slightly in how they work, how effective they are, and how well they’re tolerated.
| Feature | Semaglutide | Tirzepatide | Retatrutide |
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP receptor agonist | Triple agonist — GLP-1 + GIP + glucagon receptors |
| How it works | Slows gastric emptying, reduces appetite, improves insulin sensitivity | Same as semaglutide, plus enhanced fat metabolism and insulin response due to GIP action | All of the above, plus glucagon receptor activity that increases energy expenditure and enhances fat metabolism beyond GLP-1/GIP alone |
| Weight loss potential | ~15% of body weight (avg) | ~20%+ of body weight (avg) in trials | ~24%+ of body weight (avg) in trials |
| Onset of results | Gradual over 8–12 weeks | Often faster appetite suppression | Appetite suppression often within the first 1–2 weeks; rapid metabolic response |
| Tolerability | Nausea and GI symptoms common early | Similar, sometimes slightly more tolerable | Similar GI profile to semaglutide and tirzepatide; gradual titration recommended |
| Dosing | 0.22–2.3 mg weekly | 2–13.5 mg weekly | 1–12 mg weekly |
| Cost (compounded) | Lower | Middle | Highest |
| Best for | Mild to moderate weight loss or those preferring a gentler ramp-up | Clients wanting faster results or with insulin resistance/metabolic syndrome | Clients with higher weight loss goals, metabolic resistance, or those who have plateaued on semaglutide or tirzepatide |